Literature DB >> 2396308

Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.

A Lindholm1, S Henricsson.   

Abstract

Cyclosporine (CsA) concentrations were prospectively monitored for 6 months after transplantation in 66 consecutive renal transplant recipients. Analysis for CsA was performed with polyclonal radioimmunoassay (RIA), high-performance liquid chromatography (HPLC), and fluorescence polarization immunoassay (FPIA) in whole blood and plasma, and with specific and nonspecific monoclonal RIA in whole blood. Precision within and between runs was best with FPIA, followed by HPLC and RIA. A strong correlation was observed between the results obtained with HPLC and specific monoclonal RIA (r = 0.98). Correlation coefficients between the other assays ranged from 0.56 (plasma HPLC versus blood polyclonal RIA) to 0.91 (blood nonspecific monoclonal RIA versus blood FPIA). The highest values for CsA concentrations in blood were found with nonspecific monoclonal RIA, followed by FPIA and polyclonal RIA (mean ratio versus specific monoclonal RIA was 3.3, 2.9, and 2.4, respectively). Specific monoclonal RIA had 7% higher values than HPLC. There was a more than threefold interindividual variation in the mean ratio between specifically and nonspecifically measured CsA concentrations in whole blood and plasma. The ratio between CsA concentrations, determined with specific versus nonspecific methods in whole blood, decreased significantly during the first month after transplantation (from 0.42 to 0.35, as assayed with specific monoclonal RIA versus polyclonal RIA in whole blood; p less than 0.05). The concentrations in blood were, on the average, three times higher than those in plasma, although there was a more than fourfold interindividual variation in the mean values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396308     DOI: 10.1097/00007691-199007000-00008

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

Review 1.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation.

Authors:  S Ohlman; A Lindholm; H Hägglund; J Säwe; B D Kahan
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Monitoring of the free concentration of cyclosporine in plasma in man.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Kidney transplantation in hepatitis B surface antigen carriers.

Authors:  V Kliem; B Ringe; K Holhorst; U Frei
Journal:  Clin Investig       Date:  1994-12

Review 5.  Therapeutic monitoring of cyclosporin--an update.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.